Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapeRay is a South African medical device company that develops innovative imaging technologies for the early detection of breast cancer. The company's flagship product, Aceso, integrates digital mammography and automated breast ultrasound into a single system, enabling simultaneous image acquisition. This dual-modality approach is specifically designed to improve diagnostic sensitivity in women with dense breast tissue, where traditional mammography often fails. CapeRay's portfolio also includes systems for digital mammography and digital breast tomosynthesis. By combining multiple imaging techniques, the company aims to reduce false negatives and improve clinical outcomes in breast cancer screening. The company is a spin-out from the University of Cape Town and maintains a strong focus on research-driven diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapeRay.